Ropes, Latham Steer Cancer-Focused Biotech's $120M Float
A biotechnology company developing gene therapies to treat cancer nabbed $120 million to fund clinical trials as its shares kicked off trading Friday in an initial public offering guided by Ropes...To view the full article, register now.
Already a subscriber? Click here to view full article